You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Dev of a Sys Acaricide for Controlling Immature Stages
SBC: Biocenotics, Inc. Topic: N/ANew methodologies are being developed for interrupting the Lyme Disease transmission cycle, includiacaricides in reducing an infected tick population, control of Peromyscus spp. by environmental manirodenticidal treatment, and deer population management. A systemic, orally administered acaricide ef(particularly immature statges of Ixodes dammini), feeding on treated animals could break the tick lo ...
SBIR Phase I 1995 Department of Health and Human Services -
PORTABLE MULTIMEDIA FOR FAMILY CAREGIVER TRAINING
SBC: American Research Corporation of Virginia Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
RECOMBINANT MONOCLONAL ANTIBODIES IN YEAST
SBC: BioSavita, Inc. Topic: N/AThe use of monoclonal antibodies (MABs) in diagnostic and therapeutics applications is on the rise; yet there are limitations to the current hybridoma technology. There is a need to develop less expensive, novel and improved technologies for MAb production. The application of recombinant technology has made it possible to generate single chain, chimeric and humanized MAbs with desired specificity. ...
SBIR Phase I 1997 Department of Health and Human Services -
IDENTIFICATION OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGENS
SBC: Argonex, Inc. Topic: N/AIn the last several years there has been an explosion of information regarding the nature of peptide antigens expressed on human tumors together with class I molecules encoded in the Major Histocompatibility Complex (MHC) and recognized by cytotoxic T lymphocytes (CTL). One very successful approach aimed at the identification of these antigens, termed Direct Identification of Relevant Epitopes for ...
SBIR Phase I 1997 Department of Health and Human Services -
TACTILE GRAPHIC PRINTER PROJECT (TGPP)
SBC: Automated Functions, Inc. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
A2a--Adenosine Agonist for Cardiovascular Imaging
SBC: Discovery Therapeutics, Inc. Topic: N/AAdenosine produces coronary vasodilation through activation of A-2a adenosine receptors. However adalso acts at A1 adenosine receptors to slow atrioventricular conduction and when injected into man ican be blocked with A1 receptor antagonists. DTI has synthesized a number of adenosine analogs that2a subtype of adenosine receptor and have identified WRC-0470 as a potent selective short acting corou ...
SBIR Phase I 1995 Department of Health and Human Services -
ADENOSINE ANTAGONIST FOR CARDIOPULMONARY RESUSCITATION
SBC: Discovery Therapeutics, Inc. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
IMMUNOGLOBULIN COATINGS TO PREVENT CATHETER INFECTION
SBC: GAMMA-A TECHNOLOGIES, INC. Topic: N/ACatheters are one of the most commonly used biomaterial implants, (200 million annually in the U.S.). In long term use as for vascular central lines, the urinary tract and peritoneal dialysis, catheters are particularly susceptible to infection. These infections are resistant to antibiotic treatment and persist until removal of the device. Utilizing the concept of Passive Local Immunotherapy, (PL ...
SBIR Phase I 1997 Department of Health and Human Services -
CD ROM BASED CANCER PREVENTION PROGRAM FOR THE WORKSITE
SBC: ISA ASSOCIATES INC Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
NOVEL CHEMILUMINESCENT DETECTION OF GENE REARRANGEMENTS
SBC: LUMIGEN, INC. Topic: N/AThe objective of Phase I is to develop simple, sensitive and unambiguous chemiluminescent detection of juxtaposed genes in chromosomal translocations associated with many cancers. We propose chemiluminescent assay formats based on simultaneous probing and detection of both genes of a translocation in a single Southern blot. Phase I will prove the feasibility by developing a Southern hybridizatio ...
SBIR Phase I 1997 Department of Health and Human Services